Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 5/2008

01.10.2008 | Research Article

The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul

verfasst von: Hale Zerrin Toklu, Meral Keyer Uysal

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 5/2008

Einloggen, um Zugang zu erhalten

Abstract

Objective We investigated the knowledge and attitudes of community pharmacists towards pharmacovigilance and adverse drug reactions (ADRs) in Kadıköy district of Istanbul (Turkey). Setting The community pharmacies in Kadikoy. Kadikoy is one of the biggest districts of Istanbul and has the largest number of pharmacies. Kadikoy district was divided into two regions, the central and the peripheral. Method Between December 2005 and June 2006 we conducted a survey about the knowledge and attitude of community pharmacists (n = 219) using a face-to-face questionnaire. The questionnaire consisted of questions about the sociodemographic characteristics of the pharmacists, their knowledge of pharmacovigilance and their attitudes towards ADR reporting. Main outcomes measured The knowledge of pharmacovigilance practice, ADR reporting compliance rates, reasons for not reporting ADR and perceptions of the Turkish community pharmacists on pharmacovigilance practice were evaluated. Results Although all 411 pharmacies in the Kadikoy district were visited, only 53% of the community pharmacists (n = 219) consented to participate in the study. Of those that did respond, only 17.2% of the pharmacists had any knowledge about ‘pharmacovigilance’. Sixty-five percent of the pharmacists stated that patients reported an ADR to them during the previous 12 months, and 21% of pharmacists reported to the concerned organizations. Our survey showed that only 7% actually reported an ADR to the national pharmacovigilance center. On the other hand, 89% of the pharmacists believed that the role of the pharmacist in ADR reporting was essential. Conclusion The results show that Turkish community pharmacists have poor knowledge about pharmacovigilance. There is an urgent need for educational programs to train them about pharmacovigilance and ADR reporting.
Literatur
1.
Zurück zum Zitat Lundkvist J, Jönsson B. Pharmacoeconomics of adverse drug reactions. Fundam Clin Pharmacol. 2004;18(3):275–80.PubMedCrossRef Lundkvist J, Jönsson B. Pharmacoeconomics of adverse drug reactions. Fundam Clin Pharmacol. 2004;18(3):275–80.PubMedCrossRef
2.
Zurück zum Zitat WHO publications. The importance of pharmacovigilance: safety monitoring of medicinal products. WHO Collaborating Centre for International Drug Monitoring, Geneva, Switzerland; 2002. ISBN 92-4-159015-7. WHO publications. The importance of pharmacovigilance: safety monitoring of medicinal products. WHO Collaborating Centre for International Drug Monitoring, Geneva, Switzerland; 2002. ISBN 92-4-159015-7.
3.
Zurück zum Zitat Pirmohamed M, Atuah KN, Dodoo AN, Winstanley P. Pharmacovigilance in developing countries. BMJ. 2007;335(7618):462.PubMedCrossRef Pirmohamed M, Atuah KN, Dodoo AN, Winstanley P. Pharmacovigilance in developing countries. BMJ. 2007;335(7618):462.PubMedCrossRef
6.
Zurück zum Zitat Lee KK, Chan TY, Raymond K, Critchley JA. Pharmacists’ attitudes toward adverse drug reaction reporting in Hong Kong. Ann Pharmacother. 1994;28(12):1400–3.PubMed Lee KK, Chan TY, Raymond K, Critchley JA. Pharmacists’ attitudes toward adverse drug reaction reporting in Hong Kong. Ann Pharmacother. 1994;28(12):1400–3.PubMed
7.
Zurück zum Zitat Generali JA, Danish MA, Rosenbaum SE. Knowledge of and attitudes about adverse drug reaction reporting among Rhode Island pharmacists. Ann Pharmacother. 1995;29(4):365–9.PubMed Generali JA, Danish MA, Rosenbaum SE. Knowledge of and attitudes about adverse drug reaction reporting among Rhode Island pharmacists. Ann Pharmacother. 1995;29(4):365–9.PubMed
8.
Zurück zum Zitat Sweis D, Wong IC. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain. Drug Safety. 2000;23(2):165–72.PubMedCrossRef Sweis D, Wong IC. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain. Drug Safety. 2000;23(2):165–72.PubMedCrossRef
9.
Zurück zum Zitat Herdeiro MT, Figueiras A, Polónia J, Gestal-Otero JJ. Influence of pharmacists’ attitudes on adverse drug reaction reporting: a case–control study in Portugal. Drug Safety. 2006;29(4):331–40.PubMedCrossRef Herdeiro MT, Figueiras A, Polónia J, Gestal-Otero JJ. Influence of pharmacists’ attitudes on adverse drug reaction reporting: a case–control study in Portugal. Drug Safety. 2006;29(4):331–40.PubMedCrossRef
10.
Zurück zum Zitat Granas AG, Buajordet M, Stenberg-Nilsen H, Harg P, Horn AM. Pharmacists’ attitudes towards the reporting of suspected adverse drug reactions in Norway. Pharmacoepidemiol Drug Safety. 2007;16(4):429–34.CrossRef Granas AG, Buajordet M, Stenberg-Nilsen H, Harg P, Horn AM. Pharmacists’ attitudes towards the reporting of suspected adverse drug reactions in Norway. Pharmacoepidemiol Drug Safety. 2007;16(4):429–34.CrossRef
11.
Zurück zum Zitat Beşeri Tıbbi Ürünlerin Güvenliğinin İzlenmesi ve Değerlendirilmesi Hakkında Yönetmelik (22 Mart 2005 tarihli ve 25763 sayılı Resmi Gazete, yürürlüğe giriş tarihi: 30/06/2005) [Guide for the monitorization and evaluation of the medicinal products. Published in the official gazette in 30th March 2005 to become valid by 30th June 2005]. http://rega.basbakanlik.gov.tr/. Accessed Oct 26th, 2007. Beşeri Tıbbi Ürünlerin Güvenliğinin İzlenmesi ve Değerlendirilmesi Hakkında Yönetmelik (22 Mart 2005 tarihli ve 25763 sayılı Resmi Gazete, yürürlüğe giriş tarihi: 30/06/2005) [Guide for the monitorization and evaluation of the medicinal products. Published in the official gazette in 30th March 2005 to become valid by 30th June 2005]. http://​rega.​basbakanlik.​gov.​tr/​. Accessed Oct 26th, 2007.
12.
Zurück zum Zitat Ozcelikay G, Tekiner H. Turkiye’de Eczacılık Insan Gucunun Degerlendirilmesi ve Eczane Dagilimlari. [The distribution of the pharmacies in Turkey and evaluation of Pharmacist resources in Turkey]. Turkish Pharmacist Association Publications, Ankara, Turkey; 2007. ISBN 978-975-01139-4-9. Ozcelikay G, Tekiner H. Turkiye’de Eczacılık Insan Gucunun Degerlendirilmesi ve Eczane Dagilimlari. [The distribution of the pharmacies in Turkey and evaluation of Pharmacist resources in Turkey]. Turkish Pharmacist Association Publications, Ankara, Turkey; 2007. ISBN 978-975-01139-4-9.
13.
Zurück zum Zitat Onder Ozhan. Eczacı Profili: 1998–2007 Son On Yıla Bir Bakış [The profile of the community pharmacists: 1998–2007 An overview of the last ten years]. Turkish Pharmacist Association Publications, Ankara, Turkey; Research Series 2007. Onder Ozhan. Eczacı Profili: 1998–2007 Son On Yıla Bir Bakış [The profile of the community pharmacists: 1998–2007 An overview of the last ten years]. Turkish Pharmacist Association Publications, Ankara, Turkey; Research Series 2007.
14.
Zurück zum Zitat Hazell L, Shakir SAW. Under-reporting of adverse drug reactions: a systematic review. Drug Safety. 2006;29(5):385–96.PubMedCrossRef Hazell L, Shakir SAW. Under-reporting of adverse drug reactions: a systematic review. Drug Safety. 2006;29(5):385–96.PubMedCrossRef
16.
Zurück zum Zitat Gedde-Dahl A, Harg P, Stenberg-Nilsen H, Buajordet M, Granas AG, Horn AM. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway. Pharmacoepidemiol Drug Safety. 2007;16(9):999–1005.CrossRef Gedde-Dahl A, Harg P, Stenberg-Nilsen H, Buajordet M, Granas AG, Horn AM. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway. Pharmacoepidemiol Drug Safety. 2007;16(9):999–1005.CrossRef
17.
Zurück zum Zitat van Grootheest K, Olsson S, Couper M, de Jong-van den Berg L. Pharmacists’ role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiol Drug Safety. 2004;13(7):457–64.CrossRef van Grootheest K, Olsson S, Couper M, de Jong-van den Berg L. Pharmacists’ role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiol Drug Safety. 2004;13(7):457–64.CrossRef
Metadaten
Titel
The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul
verfasst von
Hale Zerrin Toklu
Meral Keyer Uysal
Publikationsdatum
01.10.2008
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 5/2008
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-008-9209-4

Weitere Artikel der Ausgabe 5/2008

International Journal of Clinical Pharmacy 5/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.